UpHealth CEO Martin Beck resigns; CFO Jay Jennings appointed Acting CEO

UpHealth, Inc.

Martin Beck resigned as CEO and Class I director effective July 10, 2024; no disagreements cited.
Board appointed CFO Jay Jennings as Acting CEO, effective July 11, 2024, retaining CFO role.
Lisa Fluxman promoted to President of TTC Healthcare; Jeremy Livianu reaffirmed as CLO/Secretary.
Company is now delisted from NYSE (June 2024) and trades OTC under ticker UPHL.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change (interim)

Jay Jennings

Acting Chief Executive Officer

UpHealth, Inc.

Effective: 2024-07-10
Filed: July 15, 2024, 7:59 PM ET

the Board appointed Jay Jennings, the Company’s Chief Financial Officer, to serve as the Acting Chief Executive Officer of the Company effective upon the termination of Mr. Beck as Chief Executive Officer.

Departed

Martin Beck

Chief Executive Officer

UpHealth, Inc.

Effective: 2024-07-10
Successor: Jay Jennings
Filed: July 15, 2024, 7:59 PM ET

On July 10, 2024, Martin Beck submitted a letter of resignation to the Chairman of the Board of Directors (the “Board”) of UpHealth, Inc. (the “Company”) from his positions as the Chief Executive Officer of the Company and all subsidiaries of the Company for which he serves as Chief Executive Officer.

Departed

Martin Beck

Class I Director

UpHealth, Inc.

Effective: 2024-07-10
Filed: July 15, 2024, 7:59 PM ET

he is resigning from his position as a Class I director of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jay Jennings was appointed as Acting Chief Executive Officer at UpHealth, Inc..

Action: appointed
Role: Acting Chief Executive Officer

Exact text from the filing

the Board appointed Jay Jennings, the Company’s Chief Financial Officer, to serve as the Acting Chief Executive Officer of the Company effective upon the termination of Mr. Beck as Chief Executive Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Martin Beck resigned as Chief Executive Officer at UpHealth, Inc..

Action: resigned
Role: Chief Executive Officer

Exact text from the filing

On July 10, 2024, Martin Beck submitted a letter of resignation to the Chairman of the Board of Directors (the “Board”) of UpHealth, Inc. (the “Company”) from his positions as the Chief Executive Officer of the Company and all subsidiaries of the Company for which he serves as Chief Executive Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Martin Beck resigned as Class I Director at UpHealth, Inc..

Action: resigned
Role: Class I Director

Exact text from the filing

he is resigning from his position as a Class I director of the Company, effective immediately.

View on SEC.gov

Source: SEC EDGAR

accession 0001770141-24-000089

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.